Novobiocin calcium

This classification denotes an antibiotic 2C31H35N2O11.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RHW5BU180N, chemically known as benzamide, n-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, calcium salt (2:1), but more generally known as novobiocin calcium, which bears US NIH Compound Identifier 20297. Most nations schedule novobiocin calcium under HS 29419000 and SITC 54139. As of Q4 2014, NOVOBIOCIN CALCIUM remains the US FDA Preferred Term for this commodity. Novobiocin calcium bears US NLM identifiers UMLS ID C0282264 and NCI Concept Code C81448. SMILES: CC1C(CCC2C1OC(=O)C(C2[O-])NC(=O)C3CCC(C(C3)CC=C(C)C)O)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O.CC1C(CCC2C1OC(=O)C(C2[O-])NC(=O)C3CCC(C(C3)CC=C(C)C)O)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O.[CA+2].